78 related articles for article (PubMed ID: 38672069)
1. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
2. Glioblastoma: pathology, molecular mechanisms and markers.
Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
[TBL] [Abstract][Full Text] [Related]
3. Morphological and Molecular Biological Characteristics of Experimental Rat Glioblastoma Tissue Strains Induced by Different Carcinogenic Chemicals.
Sentyabreva A; Miroshnichenko E; Artemova D; Alekseeva A; Kosyreva A
Biomedicines; 2024 Mar; 12(4):. PubMed ID: 38672069
[TBL] [Abstract][Full Text] [Related]
4. BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.
Nakajima N; Nobusawa S; Nakata S; Nakada M; Yamazaki T; Matsumura N; Harada K; Matsuda H; Funata N; Nagai S; Nakamura H; Sasaki A; Akimoto J; Hirato J; Yokoo H
Brain Pathol; 2018 Sep; 28(5):663-673. PubMed ID: 29105198
[TBL] [Abstract][Full Text] [Related]
5. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
6. Tenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarrays.
Nie S; Gurrea M; Zhu J; Thakolwiboon S; Heth JA; Muraszko KM; Fan X; Lubman DM
J Proteome Res; 2015 Feb; 14(2):814-22. PubMed ID: 25469866
[TBL] [Abstract][Full Text] [Related]
7. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
8. Morphological and molecular-biological features of glioblastoma progression in tolerant and susceptible to hypoxia Wistar rats.
Dzhalilova DS; Zolotova NA; Mkhitarov VA; Kosyreva AM; Tsvetkov IS; Khalansky AS; Alekseeva AI; Fatkhudinov TH; Makarova OV
Sci Rep; 2023 Aug; 13(1):12694. PubMed ID: 37542119
[TBL] [Abstract][Full Text] [Related]
9. Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumors.
Guo X; Gu L; Li Y; Zheng Z; Chen W; Wang Y; Wang Y; Xing H; Shi Y; Liu D; Yang T; Xia Y; Li J; Wu J; Zhang K; Liang T; Wang H; Liu Q; Jin S; Qu T; Guo S; Li H; Wang Y; Ma W
Front Oncol; 2023; 13():1200815. PubMed ID: 37483487
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma heterogeneity at single cell resolution.
Eisenbarth D; Wang YA
Oncogene; 2023 Jun; 42(27):2155-2165. PubMed ID: 37277603
[TBL] [Abstract][Full Text] [Related]
11. Changes in Oncogene Expression in Experimental Glioblastoma 101.8 Rats during Therapy with PLGA Nanoparticles Loaded with Doxorubicin.
Alekseeva AI; Gerasimov AD; Kudelkina VV; Osipova NS; Drozd SF; Pavlova GV; Kosyreva AM; Fatkhudinov TK
Bull Exp Biol Med; 2023 Feb; 174(4):518-522. PubMed ID: 36899203
[TBL] [Abstract][Full Text] [Related]
12. BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network.
Sun X; Klingbeil O; Lu B; Wu C; Ballon C; Ouyang M; Wu XS; Jin Y; Hwangbo Y; Huang YH; Somerville TDD; Chang K; Park J; Chung T; Lyons SK; Shi J; Vogel H; Schulder M; Vakoc CR; Mills AA
Nature; 2023 Jan; 613(7942):195-202. PubMed ID: 36544023
[TBL] [Abstract][Full Text] [Related]
13.
Majchrzak-Celińska A; Sidhu A; Miechowicz I; Nowak W; Barciszewska AM
J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233525
[TBL] [Abstract][Full Text] [Related]
14. Updates in IDH-Wildtype Glioblastoma.
Melhem JM; Detsky J; Lim-Fat MJ; Perry JR
Neurotherapeutics; 2022 Oct; 19(6):1705-1723. PubMed ID: 35641844
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
